Figures & data
Table 1 Clinicopathological Characteristics Of BC Patients
Table 2 The Plasma Expression Level Of miR-21 And miR-451
Figure 1 Relative expression level of miRNAs in plasma of BC patients and healthy women. The elevation of miR-21 is significant in both primary (non-recurrent) and recurrent patients compared with healthy women. The increased level of miR-451 is not significant in patients than in controls. The ratio between the interest miRNAs and the reference gene was calculated to determine relative expression levels.
![Figure 1 Relative expression level of miRNAs in plasma of BC patients and healthy women. The elevation of miR-21 is significant in both primary (non-recurrent) and recurrent patients compared with healthy women. The increased level of miR-451 is not significant in patients than in controls. The ratio between the interest miRNAs and the reference gene was calculated to determine relative expression levels.](/cms/asset/1d57731e-8236-4a5d-a4d7-d1b511aba183/dbct_a_31749630_f0001_b.jpg)
Figure 2 Validation of miR-21 in BC patients and healthy controls. Graphs of receiver operating characteristics (ROC) curve show the area under the curves (AUCs) of miR-21 for discriminating the primary BC patients (A) and the recurrent BC patients (B) from the healthy controls. The interval confidence level was 95%.
![Figure 2 Validation of miR-21 in BC patients and healthy controls. Graphs of receiver operating characteristics (ROC) curve show the area under the curves (AUCs) of miR-21 for discriminating the primary BC patients (A) and the recurrent BC patients (B) from the healthy controls. The interval confidence level was 95%.](/cms/asset/ce8af66c-edc1-4d70-afa4-b6012e7951e3/dbct_a_31749630_f0002_b.jpg)